High-Dose Etoposide, Cyclophosphamide and Total Body Irradiation with Allogeneic Bone Marrow Transplantation for Resistant Acute Myeloid Leukemia: A Study by the North American Marrow Transplant Group-Reference-Cited by-同舟云学术

High-Dose Etoposide, Cyclophosphamide and Total Body Irradiation with Allogeneic Bone Marrow Transplantation for Resistant Acute Myeloid Leukemia: A Study by the North American Marrow Transplant Group

Published:1996-01 Issue:3-4 Volume:22 Page:271-277
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Brown Randy A.,Wolff Steve N.,Fay Joseph W.,Pineiro Luis,Collins Robert H.,Lynch Joseph P.,Stevens Donald,Greer John,Herzig Roger H.,Herzig Geoffrey P.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199609051758

Reference32 articles.

1. A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.

2. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.

3. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.

4. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2

5. Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience review;Frontiers in Oncology;2022-10-03

2. Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI;Hematological Oncology;2022-07-10

3. Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia;Acta Haematologica;2020-06-30

4. Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis;Leukemia;2019-05-30

5. Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia;Annals of Hematology;2017-12-18